Skip to main content
. 2020 Oct 15;15(10):e0240335. doi: 10.1371/journal.pone.0240335

Fig 2.

Fig 2

eGFR (CKD-EPI formula) before Belatacept association (pre) and at last follow-up (last) in overall population (panel a) and early- or late-converted patients (panel b).